This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.
On Monday, biotech company Moderna launched phase three of its coronavirus vaccine trial with 30,000 participants in the U.S.
Moderna received an additional $472 million from the U.S. government to support the development of its coronavirus vaccine. It has now received about $955 million for its work. The biotech company said it remains on track to be able to deliver about 500 million doses of a vaccine per year.
5 Live is KTLA’s digital-only newscast and streams on KTLA.com and the KTLA 5 News app weekdays at 4 p.m.
Follow our Facebook group: https://www.facebook.com/groups/KTLA5Live/.
This segment aired on July 27, 2020.
